The full agenda, reports and minutes of today's meeting of the Strathclyde Pension Fund Committee are now available.





The committee approved:

  • a number of recommendations resulting from a review of the Fund's Strathclyde Direct Investment Portfolio

  • a new investment of £15m from the Direct Investment Portfolio into Epidarex Capital III LP, A Scottish life sciences venture capital fund

  • the conclusions of a review of the Strathclyde (No.3) Pension Fund and

  • a final response to the current review of the structure of the Local Government Pension Scheme in Scotland.    

The committee also considered a number of administration, audit, finance and investment reports.

The Fund's total return for Q3 2018 (to end September) was +2.6%.